• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down3.39% Nasdaq Down4.12%

    TG Therapeutics, Inc. (TGTX)

    -NasdaqCM
    6.05 Down 0.67(9.97%) Jun 24, 4:00PM EDT
    |After Hours : 6.05 Down 0.00 (0.00%) Jun 24, 4:51PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 152   152   152  
    Cost of Revenue -   -   -  
    Gross Profit 152   152   152  
    Operating Expenses
    Research Development47,707  40,086  13,663  
    Selling General and Administrative15,625  15,787  6,658  
    Non Recurring -   -  2,798  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (63,180) (55,721) (22,966)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,204  871  3,441  
    Earnings Before Interest And Taxes(61,976)(54,851)(19,525)
    Interest Expense973  931  953  
    Income Before Tax(62,949)(55,781)(20,478)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(62,949)(55,781)(20,478)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (62,949) (55,781) (20,478)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (62,949) (55,781) (20,478)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.